U.S. Food and Drug Administration (FDA) · United States

FDA Off-Label Promotion of GLP-1 Weight Loss (Ozempic, Wegovy)

GLP-1 ads must not promote diabetes-only brands for weight loss, imply compounded products are FDA-approved or equivalent to brands, guarantee results, or omit risk information for branded drugs.

21 U.S.C. 352(a), (n), (bb), 353a, 353b; 21 CFR 202.1(e)

What is FDA Off-Label Promotion of GLP-1 Weight Loss (Ozempic, Wegovy)?

GLP-1 ads must not promote diabetes-only brands for weight loss, imply compounded products are FDA-approved or equivalent to brands, guarantee results, or omit risk information for branded drugs. Apply to GLP-1 ads from drug makers, telehealth platforms, med spas, clinics and compounding pharmacies.

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, patients, customers · Prescription Drug, Healthcare Services · healthcare

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2024-10-15

What does this rule require?

GLP-1 ads must not promote diabetes-only brands for weight loss, imply compounded products are FDA-approved or equivalent to brands, guarantee results, or omit risk information for branded drugs.

How can marketing teams comply?

Apply to GLP-1 ads from drug makers, telehealth platforms, med spas, clinics and compounding pharmacies.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (FDA)
Jurisdiction
United States
Official citation
21 U.S.C. 352(a), (n), (bb), 353a, 353b; 21 CFR 202.1(e)
Published
2026-11-16
Effective date
2024-10-15
Channel
all_channels
Products
Prescription Drug, Healthcare Services
Audiences
general_audience, general_adults_18plus, patients, customers

Frequently asked questions

What is FDA Off-Label Promotion of GLP-1 Weight Loss (Ozempic, Wegovy)?

GLP-1 ads must not promote diabetes-only brands for weight loss, imply compounded products are FDA-approved or equivalent to brands, guarantee results, or omit risk information for branded drugs.

Who does this rule apply to?

general_audience, general_adults_18plus, patients, customers · Prescription Drug, Healthcare Services · healthcare

Where does this rule apply?

United States

Which marketing channels are covered?

all_channels

When does this rule take effect?

2024-10-15

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan